Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2007

01-08-2007

Prognostic Factors in Primary Gastric Lymphoma

Authors: Heriberto Medina-Franco, MD, Santos Soto Germes, MD, Carmen Lome Maldonado, MD

Published in: Annals of Surgical Oncology | Issue 8/2007

Login to get access

Abstract

Background

There is not a gold standard in the treatment of primary gastric lymphoma (PGL). This study aimed to establish prognostic factors that should be considered for the staging and management of this disease.

Methods

We retrospectively reviewed and analyzed the clinicopathological features of patients treated for PGL in a tertiary referral center in Mexico City in a 10-year period from 1990 through 2000. Staging was performed with the Ann-Arbor system. Overall and disease-free survivals were the primary endpoints.

Results

We identified 41 patients of which 19 (46.3%) were classified as large-cell lymphoma, 16 (39.0%) as low-grade MALT, and 6 (14.6%) patients as lymphoma unspecified. The series included 15 (36.6%) patients with stage IV disease. Twenty patients (48.8%) underwent surgery and 34 (82.1%) received chemotherapy. Twenty-three patients were treated with at least two different types of therapy (56.1%). Actuarial 1 and 5 years survival were 77.8 and 71.2%, respectively. Early stage at presentation, surgery, normal lactic dehydrogenase (LDH) levels and good performance status were associated with longer survival in univariate analysis. Only normal LDH and good performance status retained their significance in multivariate analysis. Regarding disease-free survival in multivariate analysis, only normal LDH was associated with a better prognosis: 131 versus 12 months for LDH <197 and ≥197 mg/dl, respectively (P < 0.0001).

Conclusions

Optimal treatment of PGL remains controversial. High LDH levels and poor performance status at diagnosis are associated with shorter overall and disease-free survival and should be considered for the staging and management of these patients.
Literature
1.
Al-Akwaa AM, Siddiqui N, Al-Mofleh IA. Primary gastric lymphoma. World J Gastroenterol 2004; 10:5–11PubMed
2.
Nakamura S, Matsumoto T, Lida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 2003; 97:2462–2473PubMedCrossRef
3.
Kodera Y, Yamamura Y, Nakamura S, et al. The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. Ann Surg 1998; 227:45–50PubMedCrossRef
4.
Ranaldi R, Goteri G, Baccarini MG, Mannello B, Bearzi I. A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. J Clin Pathol 2002; 55:346–351PubMed
5.
Koch P, del Valle F, Wolfgang B, et al. Primary Gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19:3861–3873PubMed
6.
Seydel J, Ullrich A, Bender R, Fischbach W, Blettner M. Helicobacter pylori and carcinogenesis of gastic B-cell lymphomas. Int J Cancer 2003; 104:646–649PubMedCrossRef
7.
Yoon SS, Coit DG, Portlock CS, Karpeh MS. The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240:28–37PubMedCrossRef
8.
Chen LT, Lin JT, Shyu RY, et al. Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001; 19:4245–4251PubMed
9.
Raderer M, Chott A, Drach J, Montalban C, et al. Chemotherapy for management of localized high-grade gastric B-cell lymphoma: how much is necessary? Ann Oncol 2002; 13:1094–1098PubMedCrossRef
10.
Koch P, del Valle F, Wolfgang BE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative management only in localized gastric lymphoma—results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19:3874–3883PubMed
11.
Bozer M, Eroglu A, Unal E, Eryavuz Y, Kocaoglu H, Demirici S. Survival after curative resection for stage IE and IIE primary gastric lymphoma. Hepatogastroenterology 2001; 48:1202–1205PubMed
12.
Kelessis NG, Vassilopoulos PP, Bai MP, Agnantis NJ, Avital SR, Rosenthal RJ. Update of the role of surgery in the multimodal treatment of MALT gastric lymphomas. Anticancer Res 2002; 22:3457–3464PubMed
13.
Brands F, Moing SP, Raab M. Treatment and prognosis of gastric lymphoma. Eur J Surg 1997; 163:803–813PubMed
14.
Aviles A, Nambo JM, Neri N, et al. The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg 2004; 240(1):44–50PubMedCrossRef
15.
Stephens J, Smith J. Treatment of primary gastric lymphoma and gastric mucosa-associated lymphoid tissue lymphoma. J Am Coll Surg 1998; 187:312–320PubMedCrossRef
16.
Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissued: report of the Clinical Advisory Committee Meeting—Ailie House, Virginia, November 1997. J Clin Oncol 1999; 17:3835–3849PubMed
Metadata
Title
Prognostic Factors in Primary Gastric Lymphoma
Authors
Heriberto Medina-Franco, MD
Santos Soto Germes, MD
Carmen Lome Maldonado, MD
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9244-0

Other articles of this Issue 8/2007

Annals of Surgical Oncology 8/2007 Go to the issue

Original Research

Is Sentinel Node Biopsy Necessary in Conservatively Treated DCIS?

OriginalPaper

Heme Oxygenase-1 Gene Promoter Polymorphism is Associated with Risk of Gastric Adenocarcinoma and Lymphovascular Tumor Invasion

Breast Oncology

Superiority of Sonographic Hematoma Guided Resection of Mammogram Only Visible Breast Cancer: Wire Localization Should be an Exception—Not the Rule

Editorial

SEER Data: It Can Be Thought Provoking, But Where Do We Go From Here?

Gastrointestinal Oncology

Critical Analysis of Treatment Failure After Complete Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Dissemination From Appendiceal Mucinous Neoplasms

OriginalPaper

Location of Rectal Cancer Within the Circumference of the Rectum Does Not Influence Lymph Node Status